Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Hydroxychloroquine  COVID-19 treatment studies for HCQ  C19 studies: HCQ  HCQ   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ Case 57% Improvement Relative Risk c19hcq.org Polat et al. HCQ for COVID-19 PEP Is post-exposure prophylaxis with HCQ beneficial for COVID-19? Prospective study of 208 patients in Turkey Fewer cases with HCQ (p=0.026) Polat et al., Medical J. Bakirkoy, 16:3, 280-6, doi:10.5222/BMJ.2020.50469 Favors HCQ Favors control
Hydroxychloroquine Use on Healthcare Workers Exposed to COVID-19 - A Pandemic Hospital Experience
Polat et al., Medical Journal of Bakirkoy, 16:3, 280-6, doi:10.5222/BMJ.2020.50469
Polat et al., Hydroxychloroquine Use on Healthcare Workers Exposed to COVID-19 - A Pandemic Hospital Experience, Medical Journal of Bakirkoy, 16:3, 280-6, doi:10.5222/BMJ.2020.50469
Sep 2020   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Small prophylaxis study of 208 healthcare workers in Turkey, 138 with high risk exposure received HCQ, while 70 with low and medium risk exposure did not. COVID-19 cases were lower in the treatment group, relative risk RR 0.43, p = 0.026. Since the control group had lower risk, the actual benefit may be larger.
risk of case, 57.0% lower, RR 0.43, p = 0.03, treatment 12 of 138 (8.7%), control 14 of 70 (20.0%), NNT 8.8.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Polat et al., 30 Sep 2020, prospective, Turkey, peer-reviewed, 3 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperHCQAll
Abstract: Original Article Med J Bakirkoy 2020;16(3):280-6 doi: 10.5222/BMJ.2020.50469 Medical Journal of Bakirkoy Hydroxychloroquine Use on Healthcare Workers Exposed to COVID-19 -A Pandemic Hospital Experience COVİD -19 Temas Öyküsü Olan Sağlık Çalışanlarında Hidroksiklorokin Kullanımı; Bir Pandemi Hastanesi Deneyimi Ozlem Polat1 , Ramazan Korkusuz2 , Murathan Berber3 ID ID ID University of Health Sciences, Bakırkoy, Dr. Sadi Konuk Training and Research Hospital, Department of Family Medicine, Istanbul, Turkey University of Health Sciences, Bakırkoy, Dr. Sadi Konuk Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey 3 University of Health Sciences, Bakırkoy, Dr. Sadi Konuk Training and Research Hospital, Employee Health Unit, Istanbul, Turkey 1 2 Received: 07.07.2020 / Accepted: 02.09.2020 / Published Online: 30.09.2020 Cite as: Polat O, Korkusuz R, Berber M. Hydroxychloroquine use on healthcare workers exposed to COVID-19 -A pandemic hospital experience. Med J Bakirkoy 2020;16(3):280-6. ABSTRACT Objective: As healthcare professionals play a role in combating the COVID-19 outbreak, the risk of disease exposure and illness increases. In our study, we aimed to measure the effectiveness of post-contact use in order to protect the healthcare professionals who work very intensively during the outbreak. Method: A total of 208 healthcare workers who applied to Employee Health Unit section between the dates 25 March-25 April 2020 with a history of contact with COVID-19 patients were included in the study. Employees were evaluated in low, moderate and high risk groups according to the Contact Risk Algorithm included in the Evaluation of Healthcare Workers Guidelines with COVID-19 theme. Three-day hydroxychloroquine treatment was initiated to 138 healthcare professionals who were considered as high risk. The treatment regimen was arranged as 2x400 mg on the first day and 2x200 mg on the 2nd and 3rd days. The COVID-19 positivity rates were analyzed according to the contact risk groups Results: There was a statistically significant difference between occupational groups according to contact risk groups (p<0.01); the rate of contact risk of nurses in the middle, and the doctors in the high risk groups was found to be significantly higher. When the COVID-19 positivity rates were analyzed according to the contact risk groups, the COVID-19 positivity rates were 9.4% in the high-, 16.3% in the moderate and 14.3% in the low-risk groups. The contact was found to be related to the COVID-19 test, and the positivity rate from contact with the patient was found to be significantly high (p<0.01). Conclusion: Recommendations about hydroxychloroquine for postexposure prophylaxis vary. Hydroxychloroquine can be a possible effective agent in postexposure prophylaxis. We think that conducting similar studies on larger samples can provide significant benefits to individuals and public health. Keywords: COVID-19, contact, healthcare workers, hydroxychloroquine ÖZ Amaç: Sağlık çalışanları COVID-19 salgını ile mücadelede rol aldıkça hastalığa maruz kalma ve hastalanma riskleri artmakta. Çalışmamızda salgın surecinde cok yoğun şekilde çalışan sağlık çalışanlarını korumak adına temas sonrası proflaksinin etkinliğini ölçmeyi amaçladık. Yöntem: Çalışan sağlığı birimine 25 Mart-25 Nisan 2020 tarihleri arasında COVID-19 hasta ile temas öyküsü ile başvuran 208 sağlık çalışanı çalışmaya dahil edildi. COVID-19 temasi..
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit